HeartSciences (HSCSW) Net Cash Flow (2021 - 2026)

HeartSciences (HSCSW) has reported Net Cash Flow for 6 consecutive years, with -$1.7 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Net Cash Flow fell 16.14% year-over-year to -$1.7 million; the trailing twelve-month figure through Apr 2026 stood at -$2.4 million (up 49.34% YoY), and the FY2026 full-year result was $558716.0, up 111.86% from the prior year.
• Net Cash Flow eased to -$1.7 million in Q2 2026 per HSCSW's latest filing, from -$841128.0 in the prior quarter.
• Across five years, Net Cash Flow topped out at $7.0 million in Q1 2024 and bottomed at -$1.7 million in Q2 2026.
• Historically, Net Cash Flow has averaged -$9382.2 across 5 years, with a median of -$841128.0 in 2025.
• The widest YoY moves for Net Cash Flow: up 709.28% in 2024, down 369.1% in 2024.
• Over 5 years, Net Cash Flow stood at -$1.2 million in 2022, then surged by 60.26% to -$475510.0 in 2023, then soared by 39.51% to -$287658.0 in 2024, then tumbled by 192.41% to -$841128.0 in 2025, then plunged by 106.89% to -$1.7 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$1.7 million, -$841128.0, and $1.7 million for Q2 2026, Q4 2025, and Q3 2025 respectively.